Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669). (2024). Annals of Medical Research, 31(9), 757. http://annalsmedres.org/index.php/aomr/article/view/4734